REDIportal: toward an integrated view of the A-to-I editingPietro D’Addabbo, Ernesto Picardi, Roni Cohen‐Fultheim et al.|Nucleic Acids Research|2024Cited by 28
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatmentGiuseppe Sconocchia, Giulio C. Spagnoli, Gabriele Toietta et al.|Life Science Alliance|2022Cited by 6
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Giuseppe Sconocchia, Francesca De Paolis et al.|Experimental Hematology and Oncology|2025Cited by 4
Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and TreatmentGiuseppe Sconocchia, Giulio C. Spagnoli, Giulia Lanzilli et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1
The CD64/CD28/CD3 ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Giuseppe Sconocchia, Francesca De Paolis et al.|Research Square|2024Cited by 0